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In August 1999, West Nile virus (genus Flavivirus, 
family Flaviviridae) was introduced into North america and 
caused an outbreak of encephalitis in humans, birds, and 
mammals in the New York City metropolitan area (Steele 
et al. 2000, Marfin and Gubler 2001). The virus was first 
identified from wild birds in Wisconsin during August 2001 
from 2 American crows (Corvus brachyrhynchos) recovered 
in Milwaukee County, southeastern Wisconsin (USGS 
NWHC 2001). During 2002, the virus spread from its original 
focus to encompass several southern and central counties, 
including Sauk County, location of the international Crane 
Foundation (ICF).
Serological and clinical findings from the initial 1999 
outbreak of WNV encompassing the Bronx Zoo in New York 
City suggested that a diverse array of captive cranes appeared 
resistant to the virus strain that was introduced (Ludwig et al. 
2002). As the disease spread, mortality in captive cranes was 
limited to sandhill cranes (Grus canadensis) near large urban 
centers with concurrent outbreaks in humans and wildlife. a 
single sandhill crane reportedly died from WNV infection at a 
zoo in Bridgeport, Conn. in fall 1999 (CDC 1999). Mortality 
of 7 Mississippi sandhill crane chicks (G. c. pulla) from New 
orleans, Louisiana in 2002 was attributed to WNv.
Despite a formal safety trial in sandhill cranes of a 
commercial equine WNv vaccine that showed minimal 
risks (West Nile-Innovator, Fort Dodge Animal Health, Fort 
Dodge, Ia.; G. H. Olsen, USGS Patuxent Wildlife Research 
Center, Laurel, Md., personal communication), ICF decided 
to withhold use of the vaccine for two primary reasons. 
Animal care staffers were concerned about physical injury 
risks to the cranes inherent with the 360 handling episodes 
needed to properly immunize the entire ICF flock of nearly 
120 cranes. in addition, Wisconsin state and national 
surveillance data suggested a low risk of exposure in Sauk 
County due to limited numbers of human, domestic animal 
and wild bird cases from outside urban centers. in Wisconsin, 
surveillance For west nile virus at the international crane FounDation 
2000-2004
bARRy K. hARtUp, International Crane Foundation, E-11376 Shady Lane Road, Baraboo, WI 53913, USA
Abstract: Between 2000 and 2004, serum samples collected annually from captive cranes at the International Crane Foundation 
(ICF) were analyzed for the presence of West Nile virus (WNV) antibodies using a plaque reduction neutralization test. Eighteen 
individual cranes representing 8 species were identified with positive titers (geometric mean = 188, range 40 – 1280, n = 29). 
Whooping cranes (Grus americana) represented the largest proportion of seropositive individuals (33%). Flock seroprevalence 
increased rapidly in 2003 and 2004 to a peak of 10%, representing a four-fold increase following index cases in 2000. None of the 
seropositive cranes, however, showed clinical signs consistent with WNV-related disease during the study. The results suggest that 
exposure of ICF captive cranes to WNV is relatively common and re-affirmed the decision to implement a limited vaccination plan 
for hatch year whooping cranes believed to be at risk of disease from WNV.
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considerably smaller human outbreaks have been limited to 
urbanized areas surrounding the cities of Milwaukee and 
Madison, 90 and 50 miles distant from ICF, respectively. 
therefore, the veterinary staff began serological monitoring 
of the cranes to understand the epidemiology of WNV 
exposure at ICF and inform future management decisions. 
The purpose of this study was to conduct annual serological 
testing to document changes in flock exposure to WNV over 
time and to identify species at risk of potentially developing 
WNV-related disease.
MethoDs
Beginning in 2000, the ICF captive crane flock was 
sampled annually for WNV antibodies from blood collected 
during October physical examinations. Blood was collected 
via jugular venipuncture, placed into serum separator tubes, 
and allowed to clot. Samples were centrifuged within 1 hour, 
and serum was decanted into cryovials for storage at -20o 
or -80oC until analysis. Serum samples from 2000 were 
shipped overnight to the New York State Animal Health 
Diagnostic Center, Ithaca, New York (as part of the National 
Surveillance for WNV in Zoological Institutions program). 
Serum samples from 2001-2004 were taken directly to the 
uSgS National Wildlife Health Center, Madison, Wis. for 
testing.
Both laboratories utilized a plaque reduction 
neutralization test (PRNT) procedure with serial dilutions of 
serum for titer determination of WNV antibodies (Lindsey et 
al. 1976, Beaty et al. 1989). A reduction of 50% viral plaque 
effect at a titer of >40 was considered positive. This test is 
particularly useful in wildlife and exotic animals because 
it does not require species-specific reagents. However, the 
use of this test to specifically detect WNV antibodies is 
complicated by the potential for bias from cross-reacting 
antibodies to St. Louis encephalitis virus (SLEV, a native 
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flavivirus) in test serum. None of the samples in this report, 
except 1 tested at Cornell due to standard procedures, were 
tested against SLEV to rule out false positive results. For 
the analysis, however, I assumed little to no exposure to 
SLEV due to the lack of human cases reported in Wisconsin 
since 1981 (CDC 2007). To my knowledge, the ICF site is 
not an endemic focus of SLEV activity; hence, I believe the 
potential for bias in the serological findings of this study are 
minimal.
The data were summarized by calculating annual 
seroprevalence (no. positive/total no. tested) and the 
incidence of new and repeat seropositive cranes (seropositive 
2 years in a row) in the flock. A chi-square analysis for linear 
trend in proportions was conducted to determine whether the 
flock seroprevalence had increased over the duration of the 
study (CDC 2005).
results
Eighteen individual cranes representing 8 species 
of Gruidae were identified with positive titers for WNV 
antibodies between 2000 and 2004 at ICF (Table 1). The 
geometric mean of the positive titers = 188 (range 40 – 
1280, n = 26). Six females and 12 males were seropositive. 
This difference was statistically non-significant given the 
equal sex ratio of the ICF captive crane flock. All but 2 of 
the seropositive cranes were adults 5 years of age or older. 
The mean age of the flock during the study period was 
approximately 14 years (range 4 months – 41 years); of the 
seropositive cranes, 8 were younger and 10 were older than 
the mean age. A seropositive hatch-year male whooping 
crane (G. americana) was detected in 2003 (hatch year 
cranes were first tested in 2001 and ranged from 4-7% of the 
cranes tested annually). A seropositive 2 year old subadult 
male whooping crane was identified in 2004. Whooping 
cranes represented the largest proportion of seropositive 
individuals (33%), consistent with their overall proportion in 
the captive flock during this time period (~25-30%). Cranes 
of both wild and captive origins were seropositive. None of 
the seropositive cranes showed clinical signs consistent with 
WNV-related disease (Hansen et al. 2008).
The prevalence of cranes positive for WNV antibodies 
increased during the surveillance period (χ2 = 13.8, P < 0.001; 
Table 2). Newly seropositive and repeat seropositive cranes 
were most abundant in 2003 and 2004. Five birds exhibited 
repeat positive test results the year following a positive titer; 
3 birds showed four- to eight-fold decreases in their titers, but 
2 birds showed four-fold increases. One male Siberian crane 
(G. leucogeranus) was seropositive (titer >160) for 3 straight 
years. Two male wattled cranes (Bugeranus carunculatus) 
had low positive titers in 2000 before WNV had officially 
reached Wisconsin, and then showed considerable variation 
in PRNT results in the subsequent 4 years.  The first (#5-
10, captured in eastern Africa in 1979) had titers of 80, <20, 
80, 320, <20, while the second (#5-22, captured in southern 
Africa in 1981) had titers of 40, <20, 20, 160, 20 from 2000 
to 2004, respectively. Only the 2000 titer from #5-10 (80) 
was tested against SLev, with negative results. in addition, 
a female wattled crane housed with #5-22 (#5-21, captured 
in southern Africa in 1974) exhibited a low positive titer of 
40 in 2002.
Discussion
An increasing number of cranes in the ICF captive 
flock were found to have antibodies to WNV following 
the documented arrival of the virus in Wisconsin in 2001. 
Exposure to WNV occurred in 8 species, 3 of the 4 genera 
Table 1. Species distribution of cranes with positive WNV 
antibody tests at the International Crane Foundation 2000-
2004.
Species No. positive
No. 
tested
Whooping crane (Grus americana) 6 52
Wattled crane (Bugeranus carunculatus) 3 9
Siberian crane (G. leucogeranus) 3 16
Hooded crane (G. monacha) 2 11
Sarus crane (G. antigone) 1 3
Red-crowned crane (G. japonensis) 1 8
White-naped crane (G. vipio) 1 9
Blue crane (Anthropoides paradiseae) 1 2
Table 2. Annual serological results from WNV surveillance on 
the ICF captive crane flock 2000-2004.
No. 
positive
No. 
new 
pos.
No. 
repeat 
pos.
No. 
tested
% 
positive
2000 2 2 na 84 2.4
2001 0 0 0 112 0.0
2002 3 3 0 119 2.5
2003 9 7 2 121 7.4
2004 12 8 4 119 10.1
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within the family gruidae, was widely distributed among 
cranes used for display and breeding purposes, and did not 
exhibit a significant age or sex predilection based on current 
flock demographics. A few individual cranes showed what 
appeared to be persistent titers, or changes consistent with 
re-exposure with subsequent elevations or waning titers. 
Flock seroprevalence increased rapidly, approximately four-
fold in 2 years following index cases in 2000. unfortunately, 
definitive identification of the first crane to develop an 
elevated titer in response to WNV exposure was complicated 
by the presence of low positive titers in the 3 wattled cranes 
during 2000 and 2002.
I suspect that the antibody present in these wattled cranes 
was either a non-specific cross-reacting antibody, such as 
anti-SLEV (thus providing a false positive test result), a 
waning titer from an antibody response earlier in the year, or 
possibly remnant antibody from historical WNV exposure, 
perhaps dating prior to capture in Africa. The 2000 results 
from #5-10, however, suggest the antibody present was 
specific to WNV or possibly another, unknown flavivirus. 
Unfortunately, no samples exist from earlier in the same 
year to aid in detection of changing titers in these cases. 
Additional testing of these cranes’ banked fall serum samples 
is warranted to at least establish their serological status prior 
to the 1999 introduction of WNV to North America. If the 
wattled crane results reported here from 2000 and 2002 are 
falsely positive, then a single index case occurred during 
2002 in an adult male Siberian crane, distinguished by a 
elevated titer >160. This was followed by a modest increase 
in the number of seropositive cranes in 2003 and 2004.
Our fall sampling strategy after mosquito season 
was designed to maximize detection of rising or waning 
antibody from late summer infections. The seasonal peak 
in transmission of WNV in temperate areas is typically 
from July to October (Gerhardt 2006). The prevalence 
and magnitude of the positive titers reported in this study 
appear consistent with limited, endemic exposures to 
WNV. A small number of wild sandhill cranes sampled in 
nearby Briggsville, Wisconsin during July to September and 
beginning in 2001, first showed antibodies to WNV in 3 of 14 
(21%) cranes captured in 2003 (J. A. Langenberg, Wisconsin 
DNR, Madison, Wis., personal communication).
Despite flock seroprevalence surpassing 10% by 2004, 
no clinical cases of WNV-related disease were documented 
during the study, affirming initial observations that cranes 
in general may be resistant to the introduced strain of 
WNV, excepting perhaps sandhill cranes and/or young or 
compromised birds. Susceptibility to disease and mortality 
from WNv varies markedly for adult and young birds based 
on data from Old World bird species, with higher incidence 
of circulating antibodies commonly found in adults (Rappole 
et al. 2000). Despite being detected in dead specimens of at 
least 138 species of New World birds, low viremias in many 
species suggests that WNV may only be a contributory factor 
in what otherwise are natural deaths (Gerhardt 2006). West 
Nile virus infection may require underlying illness, stress 
or immunocompromise in a crane host to result in death 
(Komar et al. 2003).
There did not appear to be any clusters of seropositive 
cranes in this study that would suggest transmission via direct 
contact, water or mechanical vectors (only 2 pairs exhibited 
simultaneous seropositive tests in both individuals in a 
given year). Meece et al. (2006) described a large outbreak 
of WNV in exotic waterfowl that was likely propagated 
by non-vector routes, particularly waterborne and direct 
contact transmission (facilitated by behavioral factors such 
as agonistic encounters and cannibalism) in overcrowded 
conditions. At ICF, I expect that competent ornithophilic 
mosquito vector(s) such as Culex sp. transmitted the virus to 
the cranes (Hayes et al. 2005), but that the spatial and social 
management of the flock (low host density, distinct pairs 
with large pens, unoccupied buffer space surrounding each 
pair, and limited surface water in bird areas), combined with 
presumably poor host competence for virus amplification 
(e.g., as established experimentally in American coots 
[Fulica americana], Order Gruiformes; Komar et al. 2003), 
limited both vector and non-vector transmission. To date, 
no targeted mosquito control efforts have been considered 
at iCF.
Preventive management of WNV in captive cranes at 
ICF currently includes limited vaccination of hatch-year 
whooping cranes based on concerns regarding susceptibility 
to sub-clinical and overt disease in younger, cohort reared 
cranes with developing immune systems. Vaccination of the 
adult whooping crane flock at ICF should be taken under 
consideration based on the incidence of positive WNV titers 
in this species. Other preventive measures should include 
common sense control of potential mosquito breeding 
sites in crane areas (eliminating unneeded standing water 
in containers or at construction sites etc.) and following 
biosecurity measures between crane pens during daily 
servicing routines (which also aids in preventing potential 
occupational exposures).
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